180 related articles for article (PubMed ID: 37304233)
21. Pelargonidin inhibits vascularization and metastasis of brain gliomas by blocking the PI3K/AKT/mTOR pathway.
Tian Z; Sun C; Liu J
J Biosci; 2022; 47():. PubMed ID: 36226369
[TBL] [Abstract][Full Text] [Related]
22. Lactate engages receptor tyrosine kinases Axl, Tie2, and vascular endothelial growth factor receptor 2 to activate phosphoinositide 3-kinase/Akt and promote angiogenesis.
Ruan GX; Kazlauskas A
J Biol Chem; 2013 Jul; 288(29):21161-21172. PubMed ID: 23754286
[TBL] [Abstract][Full Text] [Related]
23. Shp-2 mediates v-Src-induced morphological changes and activation of the anti-apoptotic protein kinase Akt.
Hakak Y; Hsu YS; Martin GS
Oncogene; 2000 Jun; 19(28):3164-71. PubMed ID: 10918571
[TBL] [Abstract][Full Text] [Related]
24. High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors.
Smit DJ; Cayrefourcq L; Haider MT; Hinz N; Pantel K; Alix-Panabières C; Jücker M
Cells; 2020 Sep; 9(9):. PubMed ID: 32962206
[TBL] [Abstract][Full Text] [Related]
25. Epithelial Src homology region 2 domain-containing phosphatase-1 restrains intestinal growth, secretory cell differentiation, and tumorigenesis.
Leblanc C; Langlois MJ; Coulombe G; Vaillancourt-Lavigueur V; Jones C; Carrier JC; Boudreau F; Rivard N
FASEB J; 2017 Aug; 31(8):3512-3526. PubMed ID: 28465325
[TBL] [Abstract][Full Text] [Related]
26. Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis.
Zhang Z; Jimi E; Bothwell AL
J Immunol; 2003 Oct; 171(7):3620-6. PubMed ID: 14500659
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin (ang) 1-7 inhibits ang II-induced atrial fibrosis through regulating the interaction of proto-oncogene tyrosine-protein kinase Src (c-Src) and Src homology region 2 domain-containing phosphatase-1 (SHP-1)).
Lu L; Cao L; Liu Y; Chen Y; Fan J; Yin Y
Bioengineered; 2021 Dec; 12(2):10823-10836. PubMed ID: 34872449
[TBL] [Abstract][Full Text] [Related]
28. Electroacupuncture attenuates pulmonary vascular remodeling in a rat model of chronic obstructive pulmonary disease via the VEGF/PI3K/Akt pathway.
Zhang L; Tian Y; Zhao P; Jin F; Miao Y; Liu Y; Li J
Acupunct Med; 2022 Aug; 40(4):389-400. PubMed ID: 35216533
[TBL] [Abstract][Full Text] [Related]
29. Combine MEK inhibition with PI3K/mTOR inhibition exert inhibitory tumor growth effect on KRAS and PIK3CA mutation CRC xenografts due to reduced expression of VEGF and matrix metallopeptidase-9.
E J; Xing J; Gong H; He J; Zhang W
Tumour Biol; 2015 Feb; 36(2):1091-7. PubMed ID: 25326806
[TBL] [Abstract][Full Text] [Related]
30. Activation of the PI3K/Akt/mTOR/p70S6K pathway is involved in S100A4-induced viability and migration in colorectal cancer cells.
Wang H; Duan L; Zou Z; Li H; Yuan S; Chen X; Zhang Y; Li X; Sun H; Zha H; Zhang Y; Zhou L
Int J Med Sci; 2014; 11(8):841-9. PubMed ID: 24936148
[TBL] [Abstract][Full Text] [Related]
31. Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now?
Stefani C; Miricescu D; Stanescu-Spinu II; Nica RI; Greabu M; Totan AR; Jinga M
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638601
[TBL] [Abstract][Full Text] [Related]
32. Myriocin suppresses tumor growth by modulating macrophage polarization and function through the PI3K/Akt/mTOR pathway.
Jang H; Ojha U; Jeong JH; Park KG; Lee SY; Lee YM
Arch Pharm Res; 2023 Jul; 46(7):629-645. PubMed ID: 37468765
[TBL] [Abstract][Full Text] [Related]
33. Tumor suppressive effect of scavenger receptor class A member 5 overexpression in colorectal cancer by regulating PI3K/AKT/mTOR pathway.
Li Y; Peng F; Tan X; Wang J; Xu Y
Genes Genomics; 2021 Oct; 43(10):1189-1198. PubMed ID: 34417976
[TBL] [Abstract][Full Text] [Related]
34. The role of PI3K/Akt/mTOR signaling in dose-dependent biphasic effects of glycine on vascular development.
Tsuji-Tamura K; Sato M; Fujita M; Tamura M
Biochem Biophys Res Commun; 2020 Aug; 529(3):596-602. PubMed ID: 32736679
[TBL] [Abstract][Full Text] [Related]
35. The SHP-1 protein tyrosine phosphatase negatively modulates Akt signaling in the ghrelin/GHSR1a system.
Lodeiro M; Alén BO; Mosteiro CS; Beiroa D; Nogueiras R; Theodoropoulou M; Pardo M; Gallego R; Pazos Y; Casanueva FF; Camiña JP
Mol Biol Cell; 2011 Nov; 22(21):4182-91. PubMed ID: 21900501
[TBL] [Abstract][Full Text] [Related]
36. Protein kinase C-delta and phosphatidylinositol 3-kinase/Akt activate mammalian target of rapamycin to modulate NF-kappaB activation and intercellular adhesion molecule-1 (ICAM-1) expression in endothelial cells.
Minhajuddin M; Bijli KM; Fazal F; Sassano A; Nakayama KI; Hay N; Platanias LC; Rahman A
J Biol Chem; 2009 Feb; 284(7):4052-61. PubMed ID: 19074768
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of protein tyrosine phosphatase improves angiogenesis via enhancing Ang-1/Tie-2 signaling in diabetes.
Chen JX; Tuo Q; Liao DF; Zeng H
Exp Diabetes Res; 2012; 2012():836759. PubMed ID: 22454630
[TBL] [Abstract][Full Text] [Related]
38. Macrophages Regulate Unilateral Ureteral Obstruction-Induced Renal Lymphangiogenesis through C-C Motif Chemokine Receptor 2-Dependent Phosphatidylinositol 3-Kinase-AKT-Mechanistic Target of Rapamycin Signaling and Hypoxia-Inducible Factor-1α/Vascular Endothelial Growth Factor-C Expression.
Guo YC; Zhang M; Wang FX; Pei GC; Sun F; Zhang Y; He X; Wang Y; Song J; Zhu FM; Pandupuspitasari NS; Liu J; Huang K; Yang P; Xiong F; Zhang S; Yu Q; Yao Y; Wang CY
Am J Pathol; 2017 Aug; 187(8):1736-1749. PubMed ID: 28627412
[TBL] [Abstract][Full Text] [Related]
39. To Investigate the Occurrence and Development of Colorectal Cancer Based on the PI3K/AKT/mTOR Signaling Pathway.
Zhong J; Ding S; Zhang X; Di W; Wang X; Zhang H; Chen Y; Zhang Y; Hu Y
Front Biosci (Landmark Ed); 2023 Feb; 28(2):37. PubMed ID: 36866550
[TBL] [Abstract][Full Text] [Related]
40. Differential inhibition of tumor angiogenesis by tie2 and vascular endothelial growth factor receptor-2 dominant-negative receptor mutants.
Stratmann A; Acker T; Burger AM; Amann K; Risau W; Plate KH
Int J Cancer; 2001 Feb; 91(3):273-82. PubMed ID: 11169947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
